Absolute Eczema Area and Severity Index Responses with Lebrikizumab in Patients with Moderate-to-severe Atopic Dermatitis: A Secondary Analysis of Two Phase 3 Trials

Thaçi D, Puig L, Motegi SI, Papp K, Stein Gold L, Kircik L, Sofen H, Fernández-Peñas P, Herranz P, Vestergaard C, Huang YH, Dossenbach M, Elmaraghy H, Gallo G, Rueda MJ, Casillas M, Yang C, Agell H, Falqués M, Nosbaum A. Absolute Eczema Area and Severity Index Responses with Lebrikizumab in Patients with Moderate-to-severe Atopic Dermatitis: A Secondary Analysis of Two Phase 3 Trials. Acta Derm Venereol. 2026 May 21;106. doi: 10.2340/actadv.v106.adv-2025-0160. PMID: 42163822.


Related Posts